Corporation
The Canada Life Assurance Company
- Meetings this Parliament
- 21
- With MPs
- 3
- Since Nov 2021
- 107
- Active registrations
- 1
Most recent reported meeting: Apr 29, 2026.
Lobbying by The Canada Life Assurance Company: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
In-house (corporation) In effect since Jul 6, 2026
Filed by David Harney, President and Chief Executive Officer
Lobbyists
-
Nadege Adam · Manager, Government Relations
Former designated public office holder
Formerly Director of Communications, Office of the Minister, Status of Women (2016–2016)
-
Nina Chiarelli · VP Public Policy and Government Relations
Former designated public office holder
Formerly Director of Communications, Communications, Office of the Prime Minister (2011–2011)
Formerly Director of Communication, Communications, Transport Canada (2011–2011)
Formerly Director of Communications, Communications, Indigenous and Northern Affairs Canada (2010–2010)
Formerly Manager of Question Period, Issues Management, Office of the Prime Minister (2009–2009)
- Amy Metzger · Senior Vice-President and Chief Compliance Officer
- David Harney · President & Chief Executive Officer
- David Simmonds · Senior Vice-President, Chief Marketing and Communications Officer
- Dervla Tomlin · Executive Vice-President, Chief Risk Officer
- Fabrice Morin · President and Chief Operating Officer, Canada Life (Canada)
- Jacqueline Bukaluk · Senior Vice-President and Chief Audit Executive
- John Melvin · Chief Investment Officer
- Jon Nielsen · Executive Vice-President and Chief Financial Officer
- Linda Kerrigan · Senior Vice-President and Appointed Actuary
- Matthew Pejovic · Manager, Public Policy and Government Relations
- Mike Dibden · Executive Vice-President and Chief Information Officer
- Sharon Geraghty · Executive Vice-President and General Counsel
- Teresa Kilmartin · Executive Vice-President and Chief Human Resources Officer
Institutions they may lobby: Canada Border Services Agency (CBSA), Canada Revenue Agency (CRA), Canadian Heritage (PCH), Communications Security Establishment Canada (CSEC), Competition Bureau Canada (COBU), Crown-Indigenous Relations and Northern Affairs Canada (CIRNAC), Employment and Social Development Canada (ESDC), Finance Canada (FIN), Financial Consumer Agency of Canada (FCAC), Financial Transactions and Reports Analysis Centre of Canada (FINTRAC), Health Canada (HC), House of Commons, Housing, Infrastructure and Communities Canada (HICC), Innovation, Science and Economic Development Canada (ISED), Intergovernmental Affairs Secretariat (IGA), Justice Canada (JC), Natural Resources Canada (NRCan), Office of the Privacy Commissioner of Canada (OPC), Office of the Superintendent of Financial Institutions Canada (OSFI), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Privy Council Office (PCO), Senate of Canada, Transport Canada (TC)
What they're lobbying on (10)Hide details
- Clarification of Goods and Services Tax (GST) / Harmonized Sales Tax (HST) with respect to the treatment of financial services.
- AI, with respect to the regulation of AI in financial institutions and insurance, and use and protection of data and information.
- Infrastructure investment, with respect to institutional investment and government partnerships.
- Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services
- The Personal Information Protection and Electronic Documents Act with respect to privacy, customer data, and data security
- Taxation - discussion of taxation policy for financial institutions.
- Review of the Proceeds of Crime (Money Laundering) and Terrorist Financing Act as it relates to insurance contracts.
- Pension and Retirement products and income security
- Guidelines of the Office of the Superintendent of Financial Institutions as they relate to insurance companies.
- Federal Financial Services legislation review, with respect to Financial Institutions policies, infrastructure, open banking, and financial technology
Registration 961269-224181-60. Look it up in the official Registry
Reported meetings
SpreadsheetFiled by Paul Mahon (86), David Harney (21).
-
Reported by David Harney · In-house (corporation)
- Miled Hill · Senior Policy Advisor, Prime Minister's Office (PMO)
- Shawn Grover · Senior Policy Advisor, Prime Minister's Office (PMO)
Federal Financial Services legislation review, with respect to Financial Institutions policies, infrastructure, open banking, and financial technology
-
Reported by David Harney · In-house (corporation)
- Helene Lacasse · Director, Canada Revenue Agency (CRA)
- Rémi Gagnon · Senior Policy Advisor, Finance Canada (FIN)
- Jerome Côté · Senior Policy Advisor, Finance Canada (FIN)
Taxation - discussion of taxation policy for financial institutions.
-
Reported by David Harney · In-house (corporation)
- Remi Gagnon · Senior Advisor, Finance Canada (FIN)
- Jerome Côté · Senior Policy Advisor, Finance Canada (FIN)
Taxation - discussion of taxation policy for financial institutions.
-
Reported by David Harney · In-house (corporation)
- Sarah Lawley · Assistant Deputy Minister, Health Canada (HC)
- David Jones · Director, Health Canada (HC)
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services Read more
AI, with respect to the regulation of AI in financial institutions and insurance, and use and protection of data and information.
-
Reported by David Harney · In-house (corporation)
- Kelsen Vallee · Chief Investment Officer and EVP, Privy Council Office (PCO)
- Jane Sibald · Project Management, Privy Council Office (PCO)
Infrastructure investment, with respect to institutional investment and government partnerships.
-
Reported by David Harney · In-house (corporation)
- Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
- Justine Frame · Policy Advisor, Health Canada (HC)
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services Read more
AI, with respect to the regulation of AI in financial institutions and insurance, and use and protection of data and information.
-
Reported by David Harney · In-house (corporation)
- Daniel MacDonald · Director General, Health Canada (HC)
- Margaret Sharp · Director, Health Canada (HC)
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services Read more
-
Reported by David Harney · In-house (corporation)
- Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
Infrastructure investment, with respect to institutional investment and government partnerships. Read more
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services
-
Reported by David Harney · In-house (corporation)
- Jade Mallette · Chief of Staff, Health Canada (HC)
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services Read more
-
Reported by David Harney · In-house (corporation)
- Michael Vandergrift · Deputy Minister, Natural Resources Canada (NRCan)
Infrastructure investment, with respect to institutional investment and government partnerships.
-
Reported by David Harney · In-house (corporation)
- Greg Orencsak · Deputy Minister, Health Canada (HC)
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services Read more
-
Reported by David Harney · In-house (corporation)
- Clement Gignac · Senator, Senate of Canada
Infrastructure investment, with respect to institutional investment and government partnerships. Read more
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services
-
Reported by David Harney · In-house (corporation)
- Aaron Wudrick · Director of Policy, House of Commons
Taxation - discussion of taxation policy for financial institutions. Read more
Infrastructure investment, with respect to institutional investment and government partnerships.
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services
-
Reported by David Harney · In-house (corporation)
- Guillaume Freire · Legislative Assistant, House of Commons
Infrastructure investment, with respect to institutional investment and government partnerships. Read more
AI, with respect to the regulation of AI in financial institutions and insurance, and use and protection of data and information.
-
Reported by David Harney · In-house (corporation)
- Claude Carignan · Senator, Senate of Canada
AI, with respect to the regulation of AI in financial institutions and insurance, and use and protection of data and information. Read more
Infrastructure investment, with respect to institutional investment and government partnerships.
-
Reported by David Harney · In-house (corporation)
- David Tousignant · Director General, Finance Canada (FIN)
- Khusro Saeedi · Director, Finance Canada (FIN)
- Barbara Russell · Director, Finance Canada (FIN)
Federal Financial Services legislation review, with respect to Financial Institutions policies, infrastructure, open banking, and financial technology
-
Reported by David Harney · In-house (corporation)
- Chi Nguyen · MP
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services Read more
-
Reported by David Harney · In-house (corporation)
- Maggie Chi · MP
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services Read more
-
Reported by David Harney · In-house (corporation)
- Wayne Long · Secretary of State, Finance Canada (FIN)
- Kevin Collins · Chief of Staff, Finance Canada (FIN)
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services Read more
Infrastructure investment, with respect to institutional investment and government partnerships.
-
Reported by David Harney · In-house (corporation)
- Greg Reade · Associate Assistant Deputy Minister, Finance Canada (FIN)
- Anne David · Director, Finance Canada (FIN)
- Manish Srivastava · Special Advisor to the Deputy Minister, Finance Canada (FIN)
- Khusro Saeedi · Director, Finance Canada (FIN)
Federal Financial Services legislation review, with respect to Financial Institutions policies, infrastructure, open banking, and financial technology
-
Reported by David Harney · In-house (corporation)
- Greg Orencsak · Deputy Minister, Health Canada (HC)
- Eric Costen · Associate Deputy Minister, Health Canada (HC)
- Jocelyne Voisin · Assistant Deputy Minister, Health Canada (HC)
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services Read more
-
Reported by Paul Mahon · In-house (corporation)
- Roy Karam · Director of Operations, Health Canada (HC)
- Stephanie Claxton · Special Assistant, Health Canada (HC)
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services Read more
Seeking to raise awareness about prescription drug coverage policy considerations and concerns in context of national universal pharmacare proposals directly and as a participant in the Together for Better Health Coalition. Other related initiatives include high cost drugs for rare disease and PMPRB regulations
-
Reported by Paul Mahon · In-house (corporation)
- Daniel MacDonald · Director General, Health Canada (HC)
- Margaret Sharp · Director, Health Canada (HC)
Seeking to raise awareness about prescription drug coverage policy considerations and concerns in context of national universal pharmacare proposals directly and as a participant in the Together for Better Health Coalition. Other related initiatives include high cost drugs for rare disease and PMPRB regulations Read more
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services
-
Reported by Paul Mahon · In-house (corporation)
- Manuel Dussault · Senior Director, Finance Canada (FIN)
Federal Financial Services legislation review, with respect to Financial Institutions policies, infrastructure, open banking, and financial technology
-
Reported by Paul Mahon · In-house (corporation)
- Adam Chambers · Member of Parliament
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.